Drugs / Rotigaptide
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT00901563 Comparator | Mar 2009 → Aug 2015 | heart disorder, vascular disorder | University of Edinburgh | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rotigaptide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00901563 ↗ |
| Known as | ZP-123 | “Rotigaptide (ZP-123) is a novel hexapeptide” NCT00901563 ↗ |
| Modality | Peptide | “Rotigaptide (ZP-123) is a novel hexapeptide” NCT00901563 ↗ |
| Route | Other | “By administering an intra-arterial rotigaptide infusion” NCT00901563 ↗ |